YOLFTbeta
Qingdao NovelBeam Technology Co. Ltd. A

Qingdao NovelBeam Technology Co. Ltd. A

688677 · SHG · Healthcare / Medical Devices

50.45CNY-3.62 (-6.70%)

Price History

Full chart

Market Stats

Previous Close54.07
Open54.59
Day Range50.22 – 55.00
52-Week Range35.84 – 170.18
Volume3.93M
Market Cap9.12B
P/E (TTM)52.10
Forward P/E0.00
EPS1.46
Dividend Yield0.79%
Beta0.81
50-Day Avg80.19
200-Day Avg77.93

About

Qingdao NovelBeam Technology Co.,Ltd. engages in the research and development, production, sales, and service of medical endoscopic instruments and optical products in China and internationally. The company offers IV endoscopic surgery workstation, camera system, LED cold light source, and laparoscope; OV clinic and surgery workstation; and optics products. It also provides endoscope, light source, camera system, surgical imaging system, endoscopic system, and operation room visualization solutions; optical components, optomechanical modules, and integrated systems; and technical support and value-added services. Its products are used in clinical surgery, analytical diagnostics, industrial applications, and lasers. The company was founded in 2003 and is headquartered in Qingdao, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Yao Zheng
  • Employees1.15K
  • HeadquartersNo.100 Keyuanweisi Road, Qingdao, China, 266100, China
  • Websitehttps://www.novelbeam.com

Leadership

  • Mr. Yao ZhengGM & Director · b. 1974
  • Mr. Fanghua WangDeputy GM, CFO & Board Secretary · b. 1968
  • Ms. Min MaDirector of Operations Management Center · b. 1973
  • Mr. Changming GuDeputy GM, Technical Director & Director · b. 1972
  • Mr. Rongzhuang MaoGeneral Manager of OMEK Healthcare · b. 1979
  • Mingming ChenAccounting Supervisor

Financials

Income Statement

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue51.93M67.97M73.74M139.49M181.04M200.68M252.87M275.20M309.67M476.82M470.60M442.83M602.61M
Growth (%)-+30.88%+8.48%+89.18%+29.78%+10.85%+26.00%+8.83%+12.53%+53.97%-1.31%-5.90%+36.08%
Cost of Revenue33.90M38.28M36.80M63.08M76.47M87.49M107.30M102.38M116.79M171.56M176.88M162.76M207.01M
Gross Profit18.03M29.69M36.93M76.41M104.56M113.19M145.57M172.81M192.89M305.26M293.72M280.07M602.61M
Gross Margin34.72%43.67%50.09%54.78%57.76%56.40%57.57%62.80%62.29%64.02%62.41%63.25%100.00%
Operating Expense20.96M24.00M22.37M40.99M47.26M50.04M63.00M61.83M58.95M98.94M132.76M127.13M412.60M
Operating Income-2.93M5.68M14.56M35.42M57.30M63.14M82.57M110.98M133.94M206.32M160.96M152.94M190.01M
Operating Margin-5.64%8.36%19.75%25.39%31.65%31.46%32.65%40.33%43.25%43.27%34.20%34.54%31.53%
EBITDA6.13M16.90M21.83M41.59M65.23M68.67M91.41M122.16M143.31M219.78M183.54M178.87M217.05M
EBITDA Margin11.80%24.86%29.61%29.82%36.03%34.22%36.15%44.39%46.28%46.09%39.00%40.39%36.02%
Net Income-931.36K6.62M15.54M32.77M51.09M54.55M71.93M96.35M117.73M182.57M145.71M135.35M171.60M
Net Income Margin-1.79%9.74%21.08%23.49%28.22%27.18%28.45%35.01%38.02%38.29%30.96%30.56%28.48%
R&D6.76M---16.11M22.28M28.54M30.92M41.34M59.90M65.89M54.15M72.74M
R&D as % of Total Revenue13.02%---8.90%11.10%11.29%11.24%13.35%12.56%14.00%12.23%12.07%
Interest Expense3.14M4.23M--2.11M413.48K1.04M2.04M469.76K492.04K670.90K509.84K2.99M
Interest Expense % of Total Revenue6.05%6.23%--1.16%0.21%0.41%0.74%0.15%0.10%0.14%0.12%0.50%

Balance Sheet

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets145.56M165.34M187.39M211.21M230.86M272.90M329.82M417.31M1.18B1.39B1.39B1.46B1.63B
Total Liabilities82.37M95.70M92.63M69.00M37.18M43.45M105.02M97.62M87.04M171.05M102.10M154.64M289.92M
Total Equity63.08M69.70M94.77M142.21M194.08M223.97M220.14M315.38M1.09B1.22B1.29B1.30B1.35B
Cash21.03M8.34M13.37M38.26M56.98M49.79M57.82M82.81M723.08M636.15M592.32M523.89M587.76M
Total Debt73.00M70.00M61.00M49.00M5.00M10.00M40.00M49.42M22.50M19.21M5.93M1.45M-
Net Debt51.97M61.66M47.63M10.74M-51.98M-39.79M-17.82M-33.39M-700.58M-616.94M-586.39M-522.44M-

Cash Flow

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow21.79M13.75M16.04M36.62M66.06M48.34M83.54M114.78M104.01M104.38M158.12M112.32M159.78M
Investing Cash Flow-55.19M-19.90M-7.49M-9.78M-7.27M-34.05M-41.50M-89.23M-89.53M-126.06M-92.67M-92.61M-
Financing Cash Flow28.07M-6.90M-1.87M-3.04M-39.15M-22.54M-34.37M1.31M627.25M-71.03M-110.19M-88.72M-
Capital Expenditure40.64M20.35M12.02M9.96M7.51M34.05M40.61M68.55M100.12M101.67M55.98M76.27M26.70M
Free Cash Flow-18.85M-6.61M4.02M26.65M58.55M14.29M42.93M46.22M3.89M2.70M102.14M36.05M133.08M
Dividends Paid4.13M5.64M4.90M3.57M2.02M34.31M33.70M1.89M34.79M35.66M69.31M66.75M74.09M
FCF to OCF-86.53%-48.07%25.07%72.79%88.64%29.55%51.39%40.27%3.74%2.59%64.60%32.09%83.29%
Dividend Paid to FCF-21.90%-85.35%121.94%13.41%3.44%240.16%78.49%4.09%894.82%1318.38%67.86%185.16%55.67%

Earnings

Report DateApr 28, 2021Aug 25, 2021Oct 27, 2021Apr 25, 2022Aug 24, 2022Oct 20, 2022Apr 20, 2023
EPS Estimate-------
EPS Actual0.300.380.380.300.510.690.56
Surprise-------
TimingPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-market

Key Statistics & Ratios

Market Cap9.12B
Enterprise Value10.09B
Trailing P/E52.10
Forward P/E0.00
Price / Sales13.87
Price / Book7.83
EPS1.46
Book Value11.24
Revenue (TTM)657.57M
Gross Profit (TTM)413.23M
EBITDA238.99M
Profit Margin26.25%
Operating Margin19.90%
Return on Equity12.88%
Return on Assets8.06%
Shares Outstanding119.88M
Shares Float56.04M
Beta0.81
Dividend Yield0.79%
Dividend Rate0.60
Payout Ratio41.10%

Dividends

20261×
0.60Jun 10, 2026
20251×
0.60Jun 6, 2025
20241×
0.55Jun 11, 2024
20231×
0.80Jun 14, 2023
20221×
0.29May 30, 2022
20211×
0.29May 13, 2021

Stock Splits

  • Jun 14, 20231.4:1